When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BMY - Century Therapeutics: More Attention Doesn't Mean You Should Buy Into INK Cell Therapy
Bristol-Myers Squibb Company
2024-02-01 12:36:15 ET
Summary
Century Therapeutics is a biotech focused on developing engineered natural killer cells for cancer and rheumatologic conditions.
Their first clinical product, CNTY-101, showed promising early data with a patient experiencing tumor shrinkage and a complete clinical response.
However, Century Therapeutics has a limited cash position and needs to prove the efficacy of their therapies before being considered a confident investment.